Covid-19 : Xenothera cherche les moyens de finaliser un traitement
[Article presse ] Par Frédéric Thual- La Tribune , à Nantes | 26/03/2020, 15:08 Avec...
More
Interview d'Odile Duvaux, présidente de XENOTHERA dans Les Echos
[Article Presse] Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...
More
Le XAV19 de XENOTHERA, un traitement prometteur pour les cas graves de Coronavirus
[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...
More
The first patient has been injected 2 weeks ago
[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...
More
XENOTHERA receives approval for first in man Kidney Transplant Clinical Trial
Nantes, September 11th, 2019 – XENOTHERA announces it has received Czech Republic regulatory...
More
XENOTHERA presents at ESOT 2019
XENOTHERA will participate at ESOT 2019 that will take place...
More
XENOTHERA announces receivability of its Clinical Trial Application at the Czech Republic regulatory agency for a first in man clinical trial of LIS1 in kidney transplanted patients with dose escalation.
Nantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...
MoreXenothera Announces Publication in European Journal of Clinical Investigation on Immunological Mechanisms Underlining Use of LIS1
Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...
More
XENOTHERA to raise Series A
XENOTHERA has started to gather investors for a Series A round of...
More